Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Jeffrey A. Stafford, San Diego US

Jeffrey A. Stafford, San Diego, CA US

Patent application numberDescriptionPublished
20080312307MAPK/ERK KINASE INHIBITORS - Compounds are provided for inhibition of MEK that comprise:12-18-2008
20090012059DIPEPTIDYL PEPTIDASE INHIBITORS - Compounds, pharmaceuticals, kits and methods are provided for use with DPP-IV and other S9 proteases that comprise a compound comprising:01-08-2009
20090156557KINASE INHIBITORS - Compounds are provided for use with kinases that comprise a compound selected from the group consisting of:06-18-2009
20090275750DIPEPTIDYL PEPTIDASE INHIBITORS - Methods of making compounds of the formula (I) wherein the variables are as defined herein. Also, methods of making compounds that may be used to inhibit dipeptidyl peptidase.11-05-2009
20090281092POLO-LIKE KINASE INHIBITORS - Compounds of the following formula are provided for use with kinases:11-12-2009
20090286800Glucokinase Activators - Compounds are provided for use with glucokinase that comprise the formula:11-19-2009
20090291938POLO-LIKE KINASE INHIBITORS - Compounds of the following formula are provided for use with kinases:11-26-2009
20090305998HSP90 INHIBITORS - The invention relates to HSP90 inhibiting compounds consisting of the formula:12-10-2009
20090312288KINASE INHIBITORS - Compounds are provided for use with kinases that comprise a compound selected from the group consisting of:12-17-2009
20100063054cMET INHIBITORS - Compounds of the following formula are provided for use with cMET:03-11-2010
20100069431IMIDAZOPYRIDINE COMPOUNDS - Compounds, pharmaceutical compositions, kits and methods are provided for use with glucokinase that comprise a compound selected from the group consisting of formula (I) wherein the variables are as defined herein.03-18-2010
20100075973POLO-LIKE KINASE INHIBITORS - The present invention provides PLK inhibitors of the formula03-25-2010
20100093767Mitotic Kinase Inhibitors - The invention relates to inhibitors of enzymes that disrupt the assembly and function of the mitotic spindle, compositions comprising the inhibitors of Formula (I), kits and articles of manufacture comprising the inhibitors and inhibitor compositions, and methods of using the inhibitors and inhibitor compositions. The inhibitors and inhibitor compositions are useful for treating, preventing or modulating diseases in which mitotic kinesins, including kinesin-like spindle protein (KSP), may be involved; symptoms of such diseases; or the effect of other physiological events mediated by mitotic kinesins, including KSP.04-15-2010
20100120717KINASE INHIBITORS - Compounds are provided for use with kinases that comprise a compound selected from the group consisting of formula (I) wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture in comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.05-13-2010
20100160633KINASE INHIBITORS - Compounds are provided for use with kinases that comprise a compound selected from the group consisting of:06-24-2010
20100190816KINASE INHIBITORS - Compounds, pharmaceutical compositions, kits and methods are provided for use with kinases that comprise a compound selected from the group consisting of:07-29-2010
20100216765KINASE INHIBITORS - Compounds, pharmaceutical compositions and kits are provided for use with kinases that comprise a compound selected from the group consisting of:08-26-2010
20110053873HSP90 INHIBITORS - The invention relates to HSP90 inhibiting compounds consisting of the formula: (I) wherein the variables are as defined herein. The invention also relates to pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.03-03-2011
20110082111POLO-LIKE KINASE INHIBITORS - Compounds of the following formula are provided for use with kinases:04-07-2011
20110087022Dipeptidyl Peptidase Inhibitors - Compounds, pharmaceuticals, kits and methods are provided for use with DPP-IV and other S9 proteases that comprise a member selected from the group consisting of:04-14-2011

Patent applications by Jeffrey A. Stafford, San Diego, CA US